NCT04790097View on ClinicalTrials.gov

FET-PET Directed Simultaneous In-field Boost for Primary GBM

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2020

Conditions
Glioblastoma Multiforme
Interventions
RADIATION

Moderately Hypofractionated Radiotherapy using Simultaneous In-Field Boost

"78Gy in 30 fractions on FET-PET based target volumes;~60Gy in 30 fractions on 2cm margin from MRI based target volumes;~all patients will be treated with concomitant and adjuvant temozolomide"

Trial Locations (1)

Unknown

The Franciszek Lukaszczyk Oncology Center, Bydgoszcz

All Listed Sponsors
lead

Prof. Franciszek Lukaszczyk Memorial Oncology Center

OTHER

NCT04790097 - FET-PET Directed Simultaneous In-field Boost for Primary GBM | Biotech Hunter | Biotech Hunter